Pharming Group (NASDAQ:PHAR) Earns Outperform Rating from Oppenheimer

Chronological Source Flow
Back

AI Fusion Summary

Oppenheimer reaffirmed Pharming Group's outperform rating, setting a $41 target and citing a 182.56% upside potential. Wall Street Zen upgraded to strong‑buy, Weiss Ratings held, and HC Wainwright gave a buy with a $37 target.
#Pharming Group #Oppenheimer #outperform rating #target price #analyst upgrades #stock outlook #Wall Street Zen #HC Wainwright
15/03 08:10 defenseworld.net
3 Πηγές

Pharming Group (NASDAQ:PHAR) Earns Outperform Rating from Oppenheimer

Pharming GroupOppenheimeroutperform ratingtarget priceanalyst upgradesstock outlook
15/03 08:42 defenseworld.net

Turtle Beach (NASDAQ:TBCH) Earns Outperform Rating from Oppenheimer

ΠΟΛΙΤΙΚΗCOMPANIESANALYST ARTICLES - US
15/03 08:56 defenseworld.net

Corvus Pharmaceuticals (NASDAQ:CRVS) Earns “Outperform” Rating from Oppenheimer

COMPANIESΠΟΛΙΤΙΚΗANALYST ARTICLES - US
Comments
Loading...
0